Europe Aorto-iliac Occlusive Disease Treatment Market Size & Outlook

The aorto-iliac occlusive disease treatment market in Europe is expected to reach a projected revenue of US$ 802.1 million by 2033. A compound annual growth rate of 5.3% is expected of Europe aorto-iliac occlusive disease treatment market from 2026 to 2033.
Revenue, 2025 (US$M)
$531.1
Forecast, 2033 (US$M)
$802.1
CAGR, 2026 - 2033
5.3%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe aorto-iliac occlusive disease treatment market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Europe aorto-iliac occlusive disease treatment market highlights

  • The Europe aorto-iliac occlusive disease treatment market generated a revenue of USD 531.1 million in 2025.
  • The market is expected to grow at a CAGR of 5.3% from 2026 to 2033.
  • In terms of segment, endovascular devices was the largest revenue generating device type in 2025.
  • Endovascular Devices is the most lucrative device type segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2026 to 2033.


Europe data book summary

Market revenue in 2025USD 531.1 million
Market revenue in 2033USD 802.1 million
Growth rate5.3% (CAGR from 2026 to 2033)
Largest segmentEndovascular devices
Fastest growing segmentEndovascular Devices
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationEndovascular Devices, Surgical Devices
Key market players worldwideBD, Bentley, Scitech Medical, Abbott, Boston Scientific Corp, W.L. Gore & Associates, Medtronic PLC, COOK, Terumo Corp, iVascular, Getinge AB ADR, Biotronik SE & Co., KG


Other key industry trends

  • In terms of revenue, Europe region accounted for 23.5% of the global aorto-iliac occlusive disease treatment market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 800.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Aorto-Iliac Occlusive Disease Treatment Market Companies

Name Profile # Employees HQ Website
Scitech Medical View profile 101-250 Goiânia, Goias, Brazil, South America https://www.scitechmed.com/
Bentley View profile 251-500 Hechingen, Baden-Wurttemberg, Germany, Europe https://bentley.global
Biotronik SE & Co., KG View profile - - -
Abbott View profile - - -
COOK View profile 1001-5000 Sittingbourne, Kent, United Kingdom, Europe https://www.cookfood.net/
iVascular View profile 51-100 Barcelona, Catalonia, Spain, Europe http://www.ivascular.global/
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
W.L. Gore & Associates View profile 5001-10000 Newark, New Jersey, United States, North America http://www.gore.com
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Getinge AB ADR View profile 11862 Lindholmspiren 7A, P.O. Box 8861, Gothenburg, Sweden, SE-417 56 https://www.getinge.com
Boston Scientific Corp View profile 48000 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 https://www.bostonscientific.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com

Europe aorto-iliac occlusive disease treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aorto-iliac occlusive disease treatment market will help companies and investors design strategic landscapes.


Endovascular devices was the largest segment with a revenue share of 92.56% in 2025. Horizon Databook has segmented the Europe aorto-iliac occlusive disease treatment market based on endovascular devices, surgical devices covering the revenue growth of each sub-segment from 2021 to 2033.


Europe's aorto-iliac occlusive disease (iliac disease) treatment market held the second-largest revenue market share in 2024. Increasing incidence of the PAD and government initiatives drives the growth of the market.

According to NCBI article published in December 2024,  PAD was diagnosed in 941 individuals, the prevalence of PAD was significantly higher among European patients, affecting 8.1% of this group. This elevated PAD burden in Europe directly emphasizes the growing demand for effective aorto-iliac occlusive disease treatments.

Reasons to subscribe to Europe aorto-iliac occlusive disease treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe aorto-iliac occlusive disease treatment market databook

  • Our clientele includes a mix of aorto-iliac occlusive disease treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe aorto-iliac occlusive disease treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Europe aorto-iliac occlusive disease treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe aorto-iliac occlusive disease treatment market size, by country, 2021-2033 (US$M)

Europe Aorto-Iliac Occlusive Disease Treatment Market Outlook Share, 2025 & 2033 (US$M)

Europe aorto-iliac occlusive disease treatment market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online